For investors looking for the most active stocks today, health care stocks are worth considering. For one thing, health care companies are constantly innovating to combat new diseases and outbreaks. With the monkeypox outbreak in the United States, individuals may fear another pandemic. At the same time, parts of the world are still dealing with the Covid-19 pandemic. With all…
Markets have remained bearish over the past week, with the double whammy of lingering inflation and federal interest rate hikes. However, the healthcare sector is expected to continue thriving amid surging healthcare concerns due to an aging population and the resurgence of COVID-19 cases. Furthermore, the demand for the digital healthcare industry is also soaring owing to its convenience and…
The COVID-19 pandemic brought a renewed interest into the healthcare sector, and with the surging Delta variant raging across the country, that interest isn’t expected to dissipate anytime soon. Due to that attention, many healthcare stocks have reached sky-high valuations. It’s not just companies that offer vaccines and therapies for COVID, either. In fact, the healthcare sector is one of…
The author of today’s article’s favorite healthcare stock right now is a tech stock for the healthcare industry whose software is helping revolutionize the drug discovery process. More specifically, its solution “helps big pharma find the right molecule for the right target, and it helps them do it a lot quicker than normal human research” – and it’s being used…
Dr. David Nierengarten, Managing Director and Head of Healthcare Equity Research at Wedbush Securities, sees potential in many biotech stocks, especially in the genetic-medicine and oncology spaces. For several specific genetic-medicine and oncology names that Nierengarten is particularly bullish on – including one company with a gene therapy for a rare retinal disease that causes significant vision loss (and sometimes…
Noting that “biotechnology and healthcare penny stocks are making waves in the market”, the author of today’s article highlights four biotech penny stocks to watch that have been gaining attention this year, both for developments related to the COVID-19 crisis and developments unrelated to the COVID-19 crisis. For these four biotech penny stocks to watch, CLICK HERE.
Today’s article highlights two cheap healthcare stocks that, while having suffered so far this year, have growth drivers at hand that should set them up for rebounds going forward: “The first of these great deals, a pharmaceutical company, has a blockbuster on the market, a newer drug with growing sales, and possible drug approvals in the coming months. And the…
“The number of Americans over 65 years of age is expected to double to around 98 million by 2060,” notes the author of today’s article – making the three high-yielding real estate investment trusts he proceeds to highlight (each of which owns medical buildings or housing facilities that will be in increasing demand as the country ages) potentially ideal investments…
The three stocks highlighted in today’s article offer above-average dividend yields (and the potential for years of continued dividend growth) as well as strong prospects for long-term returns, as each of the companies in question is a leader in its respective industry. As a result, the authors believe these three stocks are ideal picks for helping to build a retirement…